載入中
NYSEHealthcareMedical - Care Facilities
最新資料
US$3.88
+US$0.78 · +25.16%
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
前收盤價
US$3.88
+US$0.78 · +25.16%
盤中時間採用ET。市場資料可能有所延遲。
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
日內區間
目前US$3.88
52週區間
目前US$3.88
盤中時間採用ET。市場資料可能有所延遲。
Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers in the People’s Republic of China. It operates in two segments, Network and Hospital. The company’s services include linear accelerators and external beam radiotherapy, proton therapy system, gamma knife radiosurgery, and diagnostic imaging services. Its other treatments and diagnostic services comprise positron emission tomography-computed tomography and magnetic resonance imaging scanners. In addition, the company provides clinical support services, such as developing treatment protocols for doctors, and organizing joint diagnosis between doctors in its network and clinical research, as well as helps to recruit and determine the compensation of doctors and other medical personnel. Further, it offers radiotherapy and diagnostic equipment leasing, management services, and premium cancer and proton treatment services to hospitals, as well as teleconsultation and medical information technology services; and sells medical equipment. Additionally, the company operates specialty cancer hospitals, which offers radiation, imaging, test laboratory, inpatient, and nursing services. Concord Medical Services Holdings Limited was founded in 1997 and is headquartered in Beijing, China.
日內區間
目前US$3.88
52週區間
目前US$3.88
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（CNY） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 4.61億 CNY | 3.84億 CNY | 5.37億 CNY | 4.72億 CNY | 4.86億 CNY |
| 銷貨成本 | 4.35億 CNY | 4.63億 CNY | 6.14億 CNY | 6.24億 CNY | 5.43億 CNY |
| 毛利 | 2581.9萬 CNY | −7916.2萬 CNY | −7660.8萬 CNY | −1.52億 CNY | −5689.7萬 CNY |
| 銷售、一般及管理費用 | 2.65億 CNY | 4.53億 CNY | 3.86億 CNY | 3.73億 CNY | 4.01億 CNY |
| 營業費用 | 2.65億 CNY | 4.53億 CNY | 3.86億 CNY | 3.73億 CNY | 4.01億 CNY |
| 利息收入 | 968.4萬 CNY | 1398.2萬 CNY | 1083.2萬 CNY | 1002.1萬 CNY | 589.4萬 CNY |
| 利息支出 | 1.52億 CNY | 1.93億 CNY | 1.66億 CNY | 1.2億 CNY | 7378.9萬 CNY |
| 折舊和攤銷 | 1.49億 CNY | 1.31億 CNY | 1.28億 CNY | 1.33億 CNY | 1.04億 CNY |
| 營業利益 | −2.39億 CNY | −5.32億 CNY | −4.63億 CNY | −5.25億 CNY | −4.58億 CNY |
| 淨利 | −9281.1萬 CNY | −3.08億 CNY | −2.98億 CNY | −4.9億 CNY | −2.71億 CNY |
公司資料更新於 2026年10月11日。
近期已公布業績
近期已公布業績
| 行動 | 生效日期 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股票分割 | 2024年7月30日 | 1:10 | — | — |
股票分割 | 2014年1月16日 | 1,423:1,250 | — | — |
已生效 2024年7月30日
1:10
已生效 2014年1月16日
1,423:1,250
AI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
